-Reuters
Teva Pharmaceutical Awarded ~$5.7M Contract for Levalbuterol HCL Solution by Dept of Defense
https://sam.gov/opp/1f2dab28104a4d22a1fe3d5ab06aea9d/view
Related Posts
B of A Securities Upgrades Prothena Corp to Neutral, Announces $49 Price Target
B of A Securities upgrades Prothena Corp (NASDAQ:PRTA) from Underperform to Neutral and announces $49 price target.
Rivian Automotive Plans To Slash 6% Of Workforce: Report
Rivian Automotive Inc (NASDAQ: RIVN) is reportedly planning to slash 6% of its workforce to cut costs.